Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?
Answer from: Radiation Oncologist at Community Practice
Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
If T1-T2 with ITCs, I would not recommend PMRT. If T3 with ITCs, I would discuss the pros/cons and favor if ER-. If T4, I would recommend.
Comments
Radiation Oncologist at Radiation Oncology Associates P.C.
Would the presence of ITCs in multiple sentinel no...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
It would not. As Dr. @Sushil Beriwal noted, i...
Radiation Oncologist at Radiation Oncology Associates P.C.
Thank you.
3872
3877
3887
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
For those seeking reference data on the above question, here are a couple: Karam et al., PMID 24035330 Mittendorf et al., PMID 25488970
Sign in or Register to read more
9093
9088
10713
Related Questions
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
Would you consider radiation omission for a patient with a Stage I breast cancer with an elevated Oncotype Dx?
Would you consider once weekly radiation with a simultaneous integrated boost for a patient with node negative breast cancer with a positive margin for whom reexcision is not an option?
What are your top takeaways in Breast Cancer from ESMO 2024?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
Is keratosis follicularis (Darier disease) a contraindication to receipt of PMRT?
Would you offer ultrahypofractionated 5-fraction whole breast only for a women with ER-/HER2+/cN+ disease with pCR following neoadjuvant systemic therapy?